Ignite Creation Date:
2024-05-06 @ 1:49 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04130152
Status:
COMPLETED
Last Update Posted:
2022-10-25
First Post:
2019-10-14
Brief Title:
Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
SOLTI Breast Cancer Research Group
Organization Data
Organization:
SOLTI Breast Cancer Research Group
Class:
OTHER
Study ID:
SOLTI-1710
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SOLTI Breast Cancer Research Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |